Teradyne, Inc. · TER · FY2025 Q4 · Calendar Q1 2026

Teradyne: AI Demand Drives Record Q4 Revenue and New Long-Term Target

The supplied analysis supports a constructive but conditional view: AI-led semiconductor-test demand is broadening across compute, memory, networking, and edge AI, while robotics is improving. The one-year case still depends on sustained AI investment, execution on new products and the MultiLane venture, and whether concentrated, lumpy demand translates into durable share gains.

Reported After market closeNASDAQTechnology $62.74B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.80 Consensus $1.38
EPS surprise +30.4% Reported versus consensus
Reported revenue $1.08B Consensus $977.2M
Revenue surprise +10.9% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +13.4% Event window
SPY move -0.8% Same window
Abnormal move +14.3% Stock minus SPY
Volume 3.9× Versus trailing sessions
Subsequent drift +7.9% Up to 20 sessions
TERSPY benchmark

Ask FN2 about TER FY2025 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Relative to the prior-quarter analysis, Teradyne reported a record Q4, described AI as more than 60% of quarterly revenue, introduced a $6 billion revenue target framework, and highlighted the MultiLane joint venture. Robotics also moved closer to breakeven, while demand concentration and second-half visibility remained concerns.

Guidance delta

Management maintained its guidance stance; the supplied analysis does not identify a new quantitative guidance change.

Key takeaways

  • Q4 2025 revenue reached a quarterly record, with AI-related demand the primary growth engine.
  • Management said AI represented more than 60% of Q4 revenue and expected it to exceed 70% in Q1 2026.
  • The MultiLane joint venture expands Teradyne's data-center test capabilities.
  • Robotics was described as moving toward breakeven, with a large e-commerce customer expected to triple revenue in 2026.
  • Management introduced an evergreen model targeting $6 billion of revenue at a $12 billion-$14 billion ATE TAM.

Management priorities

  • Continue gaining share in compute, memory, and networking test.
  • Close and integrate the MultiLane joint venture in the first half of 2026.
  • Ramp new HDD, compute SLT, and IST customers.
  • Advance robotics AI capabilities and expand e-commerce deployments.
  • Use buybacks and maintain cash for opportunistic M&A.

Follow TER with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
TER EPS earnings history estimate and actual scatter chart 8 reported fiscal quarters and 4 future estimate-only quarters. Q4 '23 estimate $0.71 Q4 '23 actual $0.79, beat Q1 '24 estimate $0.33 Q1 '24 actual $0.51, beat Q2 '24 estimate $0.77 Q2 '24 actual $0.86, beat Q3 '24 estimate $0.78 Q3 '24 actual $0.90, beat Q2 '25 estimate $0.54 Q2 '25 actual $0.57, beat Q3 '25 estimate $0.79 Q3 '25 actual $0.85, beat Q4 '25 estimate $1.38 Q4 '25 actual $1.80, beat Q1 '26 estimate $2.11 Q1 '26 actual $2.56, beat Q2 '26 estimate $2.04 Q3 '26 estimate $2.08 Q4 '26 estimate $1.43 Q1 '27 estimate $2.26

Analyst Consensus ?

ConsensusBuy28 ratings
Bullish1864.3%
Neutral1035.7%
Bearish00.0%

2 unmapped firm ratings excluded from the percentages.

Analyst 52W Price Targets

$403.02Current
$116Low
$270.42Average
$550High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 30, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Baird Neutral OutperformDowngradeAug 21, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJul 30, 2026
Evercore ISI Group Outperform OutperformMaintainJul 30, 2026
Cantor Fitzgerald Overweight OverweightMaintainJul 29, 2026
UBS Buy BuyMaintainJul 20, 2026
Goldman Sachs Buy BuyMaintainJul 6, 2026
Susquehanna Positive PositiveMaintainJun 30, 2026
B of A Securities Buy BuyMaintainJun 23, 2026
JP Morgan Overweight NeutralUpgradeApr 30, 2026
Citigroup Buy BuyMaintainApr 30, 2026
Stifel Buy BuyMaintainApr 28, 2026
Keybanc Sector Weight OverweightDowngradeApr 17, 2025
Northland Capital Markets Outperform OutperformMaintainJan 31, 2025
Craig-Hallum Hold HoldMaintainOct 25, 2024
TD Cowen Outperform OutperformMaintainOct 27, 2023
Loop Capital Hold HoldMaintainMay 1, 2023
Deutsche Bank Buy BuyMaintainApr 28, 2023
Piper Sandler Neutral NeutralMaintainApr 11, 2023
Jefferies Buy BuyMaintainJan 27, 2023
DA Davidson Buy BuyMaintainJul 27, 2022
Rosenblatt Buy BuyMaintainApr 28, 2022
Credit Suisse Neutral NeutralMaintainJan 28, 2022
Cowen & Co. Outperform Market PerformUpgradeOct 28, 2021
CFRA Hold HoldMaintainApr 22, 2020
Citi Buy BuyMaintainOct 25, 2019
Stifel Nicolaus Hold HoldMaintainOct 24, 2019
Bank of America Neutral BuyDowngradeNov 20, 2018
Pacific Crest Sector Weight OverweightDowngradeOct 29, 2015
Sidoti & Co. Buy BuyMaintainSep 23, 2015
ISI Group Neutral BuyDowngradeOct 3, 2014
Show less

Named analyst price targets

Upside is calculated against the persisted current price $403.02. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Morgan StanleyAnalyst unavailable$397$361.79 -1.5%Jul 30, 2026
Robert W. BairdQuinn Fredrickson$420$359.71 +4.2%Jul 30, 2026
Evercore ISIVedvati Shrotre$420$357.42 +4.2%Jul 30, 2026
Goldman SachsAnalyst unavailable$465$320.65 +15.4%Jul 28, 2026
UBSTimothy Arcuri$500$340.06 +24.1%Jul 20, 2026
SusquehannaAnalyst unavailable$550$463.21 +36.5%Jun 30, 2026
Cantor FitzgeraldAnalyst unavailable$550$436.86 +36.5%Jun 29, 2026
Robert W. BairdAnalyst unavailable$446$457 +10.7%Jun 23, 2026
Morgan StanleyShane Brett$387$351.03 -4.0%Apr 30, 2026
Evercore ISIVedvati Shrotre$370$345.56 -8.2%Apr 30, 2026
Goldman SachsAnalyst unavailable$350$348.74 -13.2%Apr 30, 2026
Robert W. BairdAnalyst unavailable$350$306.33 -13.2%Apr 30, 2026
Stifel NicolausBrian Chin$390$402 -3.2%Apr 28, 2026
Evercore ISIAnalyst unavailable$430$401.98 +6.7%Apr 27, 2026
UBSAnalyst unavailable$440$375.21 +9.2%Apr 21, 2026
SusquehannaAnalyst unavailable$415$364.21 +3.0%Apr 9, 2026
Cantor FitzgeraldAnalyst unavailable$400$364.21 -0.7%Apr 9, 2026
Morgan StanleyShane Brett$306$318.09 -24.1%Feb 11, 2026
Northland SecuritiesGus Richard$270$281.29 -33.0%Feb 4, 2026
Stifel NicolausBrian Chin$325$280.38 -19.4%Feb 4, 2026
SusquehannaAnalyst unavailable$335$279.6 -16.9%Feb 4, 2026
Robert W. BairdAnalyst unavailable$305$282.98 -24.3%Feb 4, 2026
Goldman SachsAnalyst unavailable$300$282.98 -25.6%Feb 3, 2026
Morgan StanleyAnalyst unavailable$288$282.98 -28.5%Feb 3, 2026
Cantor FitzgeraldAnalyst unavailable$270$278.68 -33.0%Feb 3, 2026
Evercore ISIAnalyst unavailable$280$246.76 -30.5%Feb 2, 2026
RBC CapitalAnalyst unavailable$270$252.9 -33.0%Feb 2, 2026
Stifel NicolausAnalyst unavailable$280$251.87 -30.5%Jan 30, 2026
UBSAnalyst unavailable$275$234.49 -31.8%Jan 26, 2026
Stifel NicolausAnalyst unavailable$270$226.08 -33.0%Jan 14, 2026
SusquehannaAnalyst unavailable$275$217.26 -31.8%Jan 12, 2026
Vertical ResearchRobert Jamieson$220$218.05 -45.4%Jan 9, 2026
Cantor FitzgeraldAnalyst unavailable$240$190.54 -40.4%Dec 16, 2025
Goldman SachsJames Schneider$230$193.4 -42.9%Dec 15, 2025
Stifel NicolausAnalyst unavailable$225$179.63 -44.2%Dec 2, 2025
Robert W. BairdRichard Eastman$195$184.17 -51.6%Oct 31, 2025
UBSTimothy Arcuri$200$174.76 -50.4%Oct 30, 2025
SusquehannaBrian Chin$215$174.76 -46.7%Oct 30, 2025
Goldman SachsAnalyst unavailable$148$174.61 -63.3%Oct 30, 2025
Northland SecuritiesGus Richard$186$173.94 -53.8%Oct 30, 2025
Cantor FitzgeraldAnalyst unavailable$180$173.25 -55.3%Oct 29, 2025
Industrial Alliance SecuritiesAnalyst unavailable$175$146.02 -56.6%Oct 28, 2025
UBSAnalyst unavailable$165$138.16 -59.1%Oct 20, 2025
Morgan StanleyShane Brett$136$139.13 -66.3%Oct 14, 2025
Stifel NicolausAnalyst unavailable$119$132.08 -70.5%Oct 13, 2025
Northland SecuritiesGus Richard$161$141.17 -60.1%Oct 7, 2025
SusquehannaMehdi Hosseini$200$119.85 -50.4%Sep 22, 2025
Goldman SachsAnalyst unavailable$85$107.65 -78.9%Jul 30, 2025
Morgan StanleyAnalyst unavailable$100$107.65 -75.2%Jul 30, 2025
Cantor FitzgeraldAnalyst unavailable$105$90.39 -73.9%Jun 24, 2025
Morgan StanleyAnalyst unavailable$81$86.74 -79.9%Mar 14, 2025
UBSTimothy Arcuri$130$87.16 -67.7%Mar 12, 2025
Stifel NicolausBrian Chin$110$87.07 -72.7%Mar 12, 2025
Vertical ResearchAnalyst unavailable$135$108.54 -66.5%Mar 7, 2025
SusquehannaMehdi Hosseini$165$135.88 -59.1%Jan 22, 2025
Robert W. BairdRichard Eastman$140$127.94 -65.3%Jul 29, 2024
CitigroupAtif Malik$162$125.23 -59.8%Jul 26, 2024
Craig-HallumChristian Schwab$124$125.69 -69.2%Jul 26, 2024
SusquehannaMehdi Hosseini$145$124.34 -64.0%Jul 26, 2024
Northland SecuritiesGus Richard$126$125 -68.7%Jul 26, 2024
Stifel NicolausBrian Chin$140$124.34 -65.3%Jul 25, 2024
Northland SecuritiesGus Richard$136$151.45 -66.3%Jul 18, 2024
KeyBancSteve Barger$180$154.8 -55.3%Jul 12, 2024
UBSTimothy Arcuri$170$144.74 -57.8%Jun 18, 2024
KeyBancSteve Barger$149$139.51 -63.0%May 21, 2024
Goldman SachsToshiya Hari$161$131.91 -60.1%May 20, 2024
Morgan StanleyJoseph Moore$116$108.33 -71.2%Apr 8, 2024
CitigroupAnalyst unavailable$125$107.99 -69.0%Feb 6, 2023
Goldman SachsToshiya Hari$106$96.08 -73.7%Jul 27, 2022
Goldman SachsToshiya Hari$149$106.88 -63.0%Mar 12, 2022
Craig-HallumChristian Schwab$138$112.12 -65.8%Jan 30, 2022
Robert W. BairdRobert Mason CFA$142$112.02 -64.8%Jan 28, 2022
Rosenblatt SecuritiesKevin Garrigan$165$111.14 -59.1%Jan 27, 2022
SusquehannaMehdi Hosseini$150$111.14 -62.8%Jan 27, 2022
Deutsche BankSidney Ho$120$111.14 -70.2%Jan 27, 2022
Loop Capital MarketsScott Graham$202$158.1 -49.9%Jan 13, 2022
Bank of America SecuritiesVivek Arya$205$156.46 -49.1%Jan 10, 2022
Cowen & Co.Krish Sankar$150$136.79 -62.8%Oct 28, 2021
D.A. DavidsonThomas Diffely$140$111.25 -65.3%Oct 7, 2021
Wolfe ResearchBlake Gendron$158$131.98 -60.8%Apr 28, 2021
Show less

Track every rating change on TER the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Teradyne, Inc., established in 1960 and headquartered in North Reading, Massachusetts, is a global leader specializing in the creation, production, sale, and maintenance of automated testing solutions. The company's operations are categorized into four principal divisions: 1. Semiconductor Test: This segment delivers solutions for testing microchips at both the wafer and finished device package stages. These capabilities serve a wide array of sectors, including automotive, industrial, telecommunications, consumer electronics, mobile devices, cloud computing, and gaming. Notable offerings include the FLEX test platform, the J750 system for high-volume semiconductor testing, the Magnum platform specialized for memory components like flash and DRAM, and the ETS platform, which caters to the analog/mixed-signal markets for chip makers and outsourced assembly/test providers.…

Historical context

All TER earnings

Technology peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the TER recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-29T23:26:15.217423+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T23:26:15.215008+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.